US NewsDrugmaker Declines FDA Request to Pull Treatment After Patient DeathsSarepta stopped shipping Elevidys to non-ambulatory patients earlier this year.00CopyFacebookXTruthGettrLinkedInTelegramEmailSavePrintThe U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch TimesZachary StieberSenior Reporter7/21/2025|Updated: 7/22/20250:00X 1Update: Sarepta is halting all shipments of Elevidys.Original story below.We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.Share this articleLeave a commentZachary StieberSenior ReporterZachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]Author’s Selected ArticlesStates Update Food Stamp Requirements to Comply With New Federal LawNov 04, 2025Pfizer COVID-19 Vaccine Sales Drop After CDC Narrows GuidanceNov 04, 2025Children Face Higher Risk of Neurodevelopmental Disorders If Exposed to COVID-19 in Womb: StudyNov 04, 2025Trump Says SNAP Benefits Won’t Be Paid Until Government ReopensNov 04, 2025